About this episode

This episode explores the rise of Southern Europe's biotech ecosystem with insights from industry experts.

In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll hear from Hannah Franklin, associate at Biovance Capital and Pablo Gabriel Cironi Lopez, director of life science investment at Caixa Capital Risc. We examine the rise of Southern Europe’s biotech ecosystem—from Portugal’s efforts to turn strong science into startups to Spain’s growing depth of capital and talent—and what it will take for the region to compete globally. Host ⁠Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Hannah Franklin , Associate, Biovance Capital Pablo Gabriel Cironi Lopez , Director, Life Science Investment, Caixa Capital Risc Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

More episodes of BioSpace

• Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence · June 10, 2026 · 25 min

Explore listener stats, chart rankings, contacts and more on the BioSpace podcast page.